Antiepileptic Drugs Market - Forecast (2022 - 2027)

The Antiepileptic Drugs Market size in 2019 is estimated to be $ 3.45 billion, growing at a CAGR of 3.8% during the forecast period 2022-2027. The antiepileptic drug can also be known as an anti-seizure drug, developed for asymptomatic and Idiopathic treatment of epilepsy and seizures. Antiepileptic drugs can also be used for the treatment of neuropathic pain. Therapeutic Drug Monitoring can usually applied to optimize the treatment of epilepsy. Increasing incidence of neurological disorder and advancement in drugs modification are the major factors driving the growth of the market. Moreover, changing lifestyle, alcoholism, a rising geriatric population and active government support and investment further enhance the overall market demand for Antiepileptic Drugs during the forecast period 2022-2027.

Report Coverage

The report: “Antiepileptic Drugs Market - Forecast (2022-2027)” covers an in-depth analysis of the following segments of the Antiepileptic Drugs Market:

• By Drug Type : First Generation Drugs, Second Generation Drugs, Pipeline Drugs
• By Route of Administration : Oral, Intravenous
• By Spectrum Type : Narrow Spectrum, Broad Spectrum
• By Distribution Channel : Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• By Geography: North America, Europe, Asia-Pacific, and Rest of the World

Key Takeaways

• In 2019, North America dominates the Antiepileptic Drugs Market owing to the increasing prevalence of epilepsy and launches of generic drug and increasing social awareness, social acceptance, and awareness among the population.
• Increasing incidence of neurological disorder and advancement in drugs modification is driving the market growth of antiepileptic drugs.
• Detailed analysis of the Strength, Weakness, and opportunities of the prominent players operating in the market will be provided in the Antiepileptic Drugs Market report.
• Rise in medical supply shortage and increasing side effects are challenging the growth of the market.

Drug Type - Segment Analysis

Based on the Drug Type, Antiepileptic Drugs Market is segmented into First Generation Drugs, Second Generation Drugs and Pipeline Drugs. The second generation drugs segment is forecast to be the fastest-growing segment and is projected to grow at a CAGR of 2.8% during the forecast period 2022-2027. Second Generation Drugs has been the blockbuster drug for epilepsy treatment and has proved its potential in slowing the impulses of the brain and controlling the seizures. Moreover, it has an effective drug structure and its usage in most types of seizures that are contributing to the growth of this segment.

Distribution Channel - Segment Analysis

Based on the Distribution Channel, Antiepileptic Drugs Market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. In 2019, hospital pharmacies held the largest share in the Antiepileptic Drugs Market. This is mainly owing to an increasing number of patients suffering from conditions which are treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, the growing number of hospitals along with adequate reimbursement policies are also contributing to the growth of this segment.

Geography - Segment Analysis

North America dominated the Antiepileptic Drugs Market share accounting for 46% of the market in 2019. This is mainly owing to the increasing prevalence of epilepsy and launches of generic drug and increasing social awareness, social acceptance, and awareness among the population. According to the Centers for Disease Control and Prevention, about 3.4 million people are suffering from active epilepsy in the U.S., where 3 million adults and 470,000 children.

However, the Asia-Pacific region is projected to be the fastest-growing during the forecast period 2022-2027. This is owing to increasing awareness among people about health and developing healthcare infrastructure.

Drivers - Antiepileptic Drugs Market

Increasing Incidence of Neurological Disorder

Increasing incidence of neurological disorder and a rising geriatric population are some factors driving the growth of the Antiepileptic Drugs Market. According to World Health Organization, millions of people are suffering from neurological disorders and about 50 million people are suffering from epilepsy which is a common serious brain disorder is also set to increase the market growth.

Advancement in Drug Modification

Increasing advancement of drug modification and an increasing number of available Antiepileptic drugs are some factors driving the growth of the market. Moreover, advancement in drugs provide small effects on liver metabolism that converts into a lower rate of side effects further contributing to the growth of the Antiepileptic Drugs Market.

Challenges - Antiepileptic Drugs Market

A rise in medical supply shortage and increasing side effects are challenging the growth of the market. Moreover, patients are stockpiling the medicines as there is a shortage of drugs in the pharmacies are further restraining its market growth during the forecast period 2022-2027.

Antiepileptic Drugs Industry Outlook

• Product launches, Merger & Acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Antiepileptic Drugs Market. Antiepileptic drugs top 10 companies are Sanofi, Pfizer Inc., GW Pharmaceutical plc., UCB S.A., Eisai Co. Ltd., Sunovion Pharmaceuticals Inc., Lundbeck A/S, and GlaxoSmithKline plc.

Acquisitions/Product Launches:

• On September 2019, GW Pharmaceuticals plc. Launches new innovative drugs, EPIDYOLEX that are used for Dravet syndrome or Lennox Gastaut syndrome (LGS), as an adjunctive therapy of seizures.
• On January 2020, Eisai Co. Ltd. Launches a new drug FYCOMPA for the treatment of partial-onset seizures in patients aged 12 years and older.

This product will be delivered within 2 business days.